There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City. The Foundation would like to thank the sponsors whose generosity has helped make possible this important event for the carcinoid and neuroendocrine tumor community:
Presenting Sponsor
Novartis Oncology
Sponsors
Dima Family
Lexicon Pharmaceuticals
Patricia and George Mentonis
Neuroendocrine Tumor Management: The Era of Personalized Medicine is the theme of the symposium. Guests will have the opportunity to hear from three of the leading carcinoid/NET cancer specialists in the United States and internationally. Dr. Richard R.P. Warner, Director of the Center for Carcinoid and Neuroendocrine Tumors at Mt. Sinai and Medical Director of the Carcinoid Cancer Foundation, will give introductory remarks. The guest speakers will be Dr. Edward M. Wolin, Co-Director of the Carcinoid and Neuroendocrine Tumor Program at Cedars-Sinai Medical Center in Los Angeles, California, and Dr. Eugene A. Woltering, James D. Rives Professor of Surgery and Neurosciences at Louisiana State University Health Sciences Center in New Orleans, Louisiana.
Carcinoid and NETs in 2011: Now, New, Next will be the focus of Dr. Wolin’s presentation. What are the current treatments for carcinoid/NET patients and what is expected in the coming years? What is the role of personalized and biologically targeted chemotherapy in NET treatment? How do somatostain analogs work and why are they important for NET patients?
Dr. Edward Wolin
Dr. Woltering’s presentation, From the Bedside to the Laboratory and Back Again, will examine where NETs come from, how they are diagnosed, tests used for diagnosis and monitoring, therapies, and more.
Dr. Eugene Woltering
A patient panel will be presented and moderated by Gilles Frydman, founder of ACOR (Association of Cancer Online Resources), an online cancer-related community reaching over 1.5 million people weekly across the globe. Mr. Frydman is also a member of the Founding Circle, Society of Participatory Medicine.
ACOR founder Gilles Frydman
For further information, call the Carcinoid Cancer Foundation at 888-722-3132. We look forward to seeing you on May 1!
